Search Results

Clinical group leaders Sonia Gandhi and Samra Turajlic have received £4 million in competitive new fellowships from the Medical Research Council and Cancer Research UK.

An international clinical trial will use personalised detection tests to look for the earliest signs of relapse in over 300 patients with lung cancer.    

Scientists from the Crick and King’s College London have studied colorectal cancer and found that levels of specific immune cells are the best predictors of whether immunotherapy will be effective in individual patients. 

Scientists at the Crick, in collaboration with Artios, have uncovered an unappreciated role for the enzyme POLQ, providing the scientific underpinnings for a Phase I clinical trial evaluating the effects of blocking this enzyme in certain cancer patients.  

Nearly 50% of blood cancer patients do not have detectable levels of antibodies able to neutralise the Omicron SARS-CoV-2 variant after a third vaccine dose, according to new laboratory data from the Crick and The Royal Marsden NHS Foundation Trust

Scientists at the Crick have found that using immunotherapy alongside a drug that blocks a common gene mutation in lung cancer could be a promising new combination therapy for certain types of lung tumours.  

Clinician scientist Amit Samani explains how his time in the lab has shown him what happens long before treatments reach patients in the clinic.